Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA <sub>2</sub> DS <sub>2</sub> ‐VASc Score of 1 (Men) or 2 (Women)? — Yuan Hung (2016) | RDL Network
Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA <sub>2</sub> DS <sub>2</sub> ‐VASc Score of 1 (Men) or 2 (Women)?
Article 2016 en
Authors
YH
Yuan Hung
TC
Tze‐Fan Chao
CL
Chia‐Jen Liu
Abstract
1 min read
For atrial fibrillation patients aged 20 to 49 years with 1 risk factor in addition to sex, non-vitamin K antagonist OACs should be considered for stroke prevention to minimize the risk of a potentially fatal or disabling event.
Jan Steffel, Rónán Collins, Matthias Antz, Pieter Cornu, Lien Desteghe, Karl Georg Hæusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldán, Nigel Rowell, Peter Sinnaeve, Thomas Vanassche, Tatjana Potpara, A. John Camm, Hein Heidbüchel, Professor Gregory Lip, Thomas Deneke, Nikolaos Dagres, Giuseppe Boriani, Tze-Fan Chao, Eue-Keun Choi, Mellanie True Hills,
Professor Gregory Lip, Marco Proietti, Tatjana Potpara, Moussa Mansour, Irina Savelieva, Hung‐Fat Tse, Andreas Goette, A. John Camm, Carina Blomström‐Lundqvist, Dhiraj Gupta, Giuseppe Boriani
Discussion(0)
No comments yet. Be the first to comment.